Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Number of holders
-
252
-
Total 13F shares, excl. options
-
170,577,261
-
Shares change
-
+1,182,120
-
Total reported value, excl. options
-
$7,735,337,873
-
Value change
-
+$69,484,732
-
Put/Call ratio
-
238%
-
Number of buys
-
141
-
Number of sells
-
-83
-
Price
-
$45.35
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2024
285 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q3 2024.
Revolution Medicines, Inc. - Common Stock (RVMD) has 252 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 170,577,261 shares
of 186,164,820 outstanding shares and own 92% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (14,911,373 shares), BlackRock, Inc. (13,866,858 shares), WELLINGTON MANAGEMENT GROUP LLP (11,401,394 shares), FARALLON CAPITAL MANAGEMENT LLC (11,317,692 shares), BAKER BROS. ADVISORS LP (7,569,090 shares), Nextech Invest Ltd. (6,296,740 shares), JANUS HENDERSON GROUP PLC (6,137,244 shares), FMR LLC (5,875,893 shares), Paradigm Biocapital Advisors LP (5,314,089 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (5,313,305 shares).
This table shows the top 252 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.